BioLineRx Ltd. - American Depositary Shares (BLRX)

Termos de negociação

Horário de negociação (UTC)
segunda-feira: 11:00 - 00:00
terça-feira - sexta-feira: 00:00 - 00:30, 11:00 - 00:00
sábado: 00:00 - 00:30

Sobre a empresa

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

http://www.biolinerx.com